Momenta MOM-M281-006

The primary objective is to evaluate the efficacy of M281 in patients with warm autoimmune hemolytic anemia (wAIHA).

Trial overview

Topic

Momenta MOM-M281-006

Description

Efficacy and Safety of M281 in Adults with Warm Autoimmune Hemolytic Anemia: A Multicenter, Randomized, Double-blind, Placebo-controlled Study with a Long-term Open-label Extension

Physicians

Contact

Florida East Coast-Jacksonville

Maddie Hamilton